Fact-checked by Grok 2 weeks ago

Sinoatrial node

The sinoatrial node (SAN), often referred to as the sinus node, is a specialized cluster of pacemaker cardiomyocytes located at the junction of the and the upper right atrium, serving as the heart's primary by spontaneously generating electrical impulses that initiate each at a normal rate of 60 to 100 beats per minute. This node ensures coordinated atrial and ventricular contraction, maintaining rhythmic essential for systemic circulation. Anatomically, the SAN forms an elongated, crescent-shaped structure spanning approximately 11 to 30 mm in length, 2 to 6 mm in width, and 2 to 3 mm in thickness, embedded intramurally within the right atrial wall near the , with its "head" positioned subepicardially and "tail" subendocardially. Composed of specialized pacemaker cells lacking a stable resting , and interspersed with (comprising 40% to 55% ), the node features low expression of connexin-43 and sodium channels (Nav1.5) but high levels of hyperpolarization-activated cyclic nucleotide-gated channels (HCN1/HCN4), which facilitate . These cells connect to surrounding atrial myocardium via discrete sinoatrial conduction pathways (typically 2 to 5), allowing impulses to propagate up to 50 mm along the . Physiologically, the SAN's pacemaker activity arises from spontaneous diastolic depolarization in its cells, driven by ion currents such as the "funny current" (If) through HCN channels, calcium influx via L-type channels, and sodium-calcium exchanger activity, culminating in an that spreads through the atria and . Its firing rate is modulated by the : sympathetic stimulation via norepinephrine increases the rate (positive chronotropy), while parasympathetic input through slows it, enabling adaptation to physiological demands like exercise or rest. In healthy hearts, the leading pacemaker sites within the SAN's three-dimensional structure ensure reliable impulse initiation, with conduction pathways distributing the signal efficiently. Clinically, SAN dysfunction—manifesting as , , or sick sinus syndrome—can arise from , ischemia, or aging, often requiring artificial for treatment, though many cases remain and managed conservatively. Accurate mapping of its intramural anatomy is crucial for interventions like in atrial arrhythmias, as misidentification of exit sites versus true pacemaker regions can lead to procedural complications.

Anatomy

Location

The sinoatrial node is an oval- or crescent-shaped cluster of specialized pacemaker cells situated in the superior posterior wall of the right atrium, precisely at the junction where the meets the entrance of the . This positioning places it subepicardially within the sulcus terminalis, inferior to the crest of the right atrial appendage, and bordering the intercaval region of the right atrium. In adults, the node measures approximately 10-25 mm in length, 2-5 mm in width, and 1-3 mm in thickness, forming an elongated intramural structure that extends into the atrial myocardium. It lies 1-3 mm beneath the epicardium, embedded within layers of and fat that partially insulate it from surrounding atrial tissue. The node comprises distinct regions: a superior "head" near the orifice, a central "body" that is wider and more densely packed, and an inferior "tail" that narrows and penetrates deeper into the myocardium toward the inferior . It maintains close spatial relationships with adjacent structures, including proximity to the right atrial appendage superiorly, the via the laterally, and epicardial fat that surrounds its epicardial aspects.

Microanatomy

The sinoatrial node (SAN) is composed primarily of specialized pacemaker cells known as P cells, transitional cells that bridge the node to surrounding atrial myocardium, and supporting fibroblasts embedded within a dense fibrous matrix predominantly consisting of . This heterogeneous cellular makeup is encased in a structural framework that provides both and mechanical support, with fibroblasts comprising a significant portion of the nodal volume—approximately 25% in and up to 50% in larger mammals. P cells, the primary pacemaker components, are small (5–10 μm in diameter and 25–30 μm in length), spindle- or round-shaped cells with pale-staining cytoplasm due to their sparse and disorganized myofibrils, few mitochondria, and absence of . These features distinguish them from contractile cardiomyocytes, as the limited myofibrillar content and lack of reflect their reduced force-generating capacity and adaptation for rather than . Intercalated discs are present but simplified, featuring primarily gap junctions composed of connexin-45, which enables electrical among nodal cells while limiting rapid conduction to the atrium. In three-dimensional architecture, the SAN forms an elongated, intramural fibrotic band approximately 10–20 mm long and 2–3 mm wide in humans, exhibiting regional heterogeneity with clusters of P cells interspersed among transitional cells and fibroblasts. Unlike the working atrial myocardium, which features densely packed, organized sarcomeres aligned in parallel for efficient contraction, the SAN's cells lack such structured arrays, instead showing irregular distribution that supports spontaneous over synchronized force production. This fibrotic encapsulation creates a distinct , with transitional cells gradually increasing in myofibril density to facilitate .

Vascular supply

The sinoatrial node receives its primary arterial blood supply from the , a specialized branch of the that originates most commonly from the in approximately 68% of cases, with the left circumflex artery providing supply in about 22% of cases and direct origin from the occurring in roughly 3% of individuals. In cases of left-dominant , the is more likely to arise from the left circumflex, whereas right-dominant systems favor origination from the , influencing nodal patterns across populations. The typically emerges 1-2 cm distal to the and follows a variable course along the epicardial surface, often running parallel to the before penetrating the nodal tissue at its superior "head" near the junction of the and right atrium. This pathway ensures targeted delivery of oxygenated blood to the node's cells, with the artery occasionally forming an encircling ring around the in up to 30% of cases to enhance regional distribution. Venous drainage from the sinoatrial node occurs primarily through small anterior cardiac veins (also known as anterior right atrial veins), which collect deoxygenated blood from the anterior right atrial wall and empty directly into the right atrium, bypassing the . In some instances, minor tributaries may contribute to the via posterior connections, but the predominant direct drainage into the right atrium supports efficient local recirculation. Anatomical variations include dual arterial supply in approximately 2-4% of individuals, where branches from both the right coronary and left circumflex arteries converge on the , potentially offering against ischemic events. Coronary dominance significantly impacts these patterns, as right-dominant hearts (prevalent in 85% of people) predominantly rely on right coronary-derived flow, while left-dominant variants heighten dependence on left-sided vessels. Within the sinoatrial node, a rich network branches from the , forming a dense of arterioles and capillaries that provides essential metabolic support to the metabolically demanding myocytes through selective and oxygen delivery. This microvascular architecture, with reduced density observed in certain , underscores the node's vulnerability to disruptions despite its robust vascular design.

Physiology

Pacemaker mechanism

The sinoatrial node (SAN) exhibits intrinsic , generating spontaneous action potentials that initiate each through a process of diastolic during phase 4 of the . This slow, progressive of the from approximately -60 mV toward the threshold of -40 mV is driven primarily by the interplay of several ionic currents, culminating in the activation of voltage-gated calcium channels to trigger the upstroke of the action potential. Unlike contractile cardiomyocytes, SAN pacemaker cells lack a stable , enabling this rhythmic self-excitation that sets the heart's pace. Central to phase 4 depolarization is the funny current (I_f), an inward hyperpolarization-activated current mediated by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, predominantly the HCN4 isoform in the . I_f, permeable to both sodium and potassium ions, activates upon following the previous , contributing a significant portion of the early diastolic inward . Later phases of depolarization involve T-type calcium (Ca²⁺) channels (I_Ca,T), which open at more depolarized potentials to provide additional inward , and the sodium-calcium exchanger (NCX) operating in forward mode, where spontaneous sarcoplasmic reticulum calcium releases trigger NCX-mediated sodium influx and further membrane . These mechanisms collectively ensure reliable progression to the action potential threshold. Intracellular signaling modulates this automaticity via (cAMP), which binds directly to the cyclic nucleotide-binding domain of HCN channels, shifting their activation curve to more positive voltages and accelerating the rate. This cAMP-dependent allows fine-tuning of pacemaker activity, with baseline SAN firing rates of 60-100 beats per minute in humans, establishing it as the primary pacemaker. The SAN's highest intrinsic automaticity rate overdrive-suppresses subsidiary pacemakers, such as the (which fires at 40-60 beats per minute), preventing ectopic rhythms under normal conditions. Upon reaching threshold, the action potential propagates from the through transitional cells—specialized internodal pathways that bridge pacemaker cells to the surrounding atrial myocardium. These transitional zones facilitate rapid conduction of the impulse across the atria and to the , ensuring synchronized ventricular activation while the SAN maintains dominance.

Electrophysiological properties

The action potential in sinoatrial node () cells exhibits distinct morphology compared to working myocardium, lacking a stable and featuring a gradual phase 4 diastolic depolarization that leads to spontaneous firing. Unlike ventricular myocytes, SAN action potentials do not display a prominent phase 0 plateau or rapid upstroke driven by fast sodium currents; instead, the phase 0 upstroke is slower and primarily mediated by L-type calcium channels (Ca_v1.3 and Ca_v1.2), resulting in a maximum upstroke velocity (dV/dt_max) of approximately 1-10 V/s. This morphology supports , with the oscillating between a maximum diastolic potential (MDP) of around -60 mV and a peak of +10 to +20 mV during . Key ionic currents underpin this electrophysiological profile. The hyperpolarization-activated funny current (I_f), carried by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels permeable to both Na^+ and K^+, activates upon hyperpolarization during early , contributing to the slow diastolic depolarization and pacemaker activity. The delayed rectifier potassium current (I_K), including (I_{Kr}) and slow (I_{Ks}) components, facilitates during phase 3, while the "Ca^{2+} clock" involves rhythmic spontaneous sarcoplasmic reticulum Ca^{2+} releases via ryanodine receptors that activate the Na^+/Ca^{2+} exchanger (I_{NCX}) to generate inward , further driving late diastolic depolarization. A basic model of the funny is given by the equation I_f = G_f (V - E_f), where G_f represents the time- and voltage-dependent conductance, V is the membrane potential, and E_f is the reversal potential (typically around -20 to -10 mV, determined by the Na^+/K^+ permeability ratio). This simplified ohmic form approximates I_f's role in pacemaking, though full models incorporate its sigmoidal activation kinetics. The SAN's cycle length, reflecting its intrinsic firing rate, typically ranges from 600 to 1000 (60-100 beats per minute) in humans, with an MDP of approximately -60 to -65 mV observed in isolated pacemaker cells. Electrophysiological heterogeneity exists within the structure, with cells at the nodal head (superior region) exhibiting faster intrinsic rates and steeper diastolic depolarization compared to those at the tail ( junction), where cycle lengths may be 10-20% longer; this gradient ensures coordinated pacemaking from a leading site that shifts dynamically.

Innervation

Sympathetic effects

The sympathetic nervous system provides acceleratory input to the sinoatrial (SA) node primarily through postganglionic noradrenergic fibers that originate from the superior cervical and cervicothoracic (stellate) ganglia and converge in the cardiac plexus. These fibers release norepinephrine, which acts as the primary neurotransmitter to modulate SA node pacemaker activity. The right stellate ganglion contributes significantly to SA node innervation, ensuring targeted sympathetic influence on sinus rhythm generation. At the cellular level, norepinephrine binds to β1-adrenergic receptors on SA node cells, which are G-protein-coupled receptors linked to stimulatory Gαs proteins. Receptor activation stimulates adenylyl cyclase, elevating intracellular cyclic AMP (cAMP) levels, which in turn activates protein kinase A (PKA). PKA phosphorylates key ion channels, including hyperpolarization-activated cyclic nucleotide-gated (HCN) channels to enhance the funny current (I<sub>f</sub>) and L-type calcium channels to increase the L-type Ca<sup>2+</sup> current (I<sub>CaL</sub>), thereby steepening the slope of spontaneous diastolic depolarization and accelerating the pacemaker firing rate. This sympathetic modulation exerts positive effects, increasing the up to 180-200 beats per minute during peak activation, while also shortening the action potential duration to facilitate faster cycle lengths. Physiologically, these effects enable rapid adaptation of to increased demands, such as during exercise or stress, as part of the mediated by the .

Parasympathetic effects

The parasympathetic innervation of the sinoatrial (SA) node originates from the (cranial nerve X), with preganglionic fibers synapsing in intracardiac ganglia within the , from which postganglionic fibers release onto SA node cells. This neurotransmitter binds primarily to muscarinic M2 receptors on the SA node cell membrane, initiating inhibitory signaling. Activation of M2 receptors, which are G-protein-coupled receptors linked to Gi proteins, inhibits adenylate cyclase activity, leading to decreased intracellular cyclic AMP (cAMP) levels. Reduced cAMP diminishes protein kinase A phosphorylation, thereby suppressing the hyperpolarization-activated funny current (If) and L-type calcium (Ca²⁺) currents, while also activating G-protein-coupled inwardly rectifying potassium channels (IKACh) via Gβγ subunits. These changes hyperpolarize the maximum diastolic potential and slow the rate of spontaneous diastolic depolarization, thereby reducing the SA node's firing frequency. The net effect is negative chronotropy, decreasing the , which can reach 40–60 beats per minute under conditions of high parasympathetic tone at rest, such as during or in athletes. Parasympathetic also shortens the action potential duration in SA node cells by accelerating through increased conductance. The right provides the predominant parasympathetic input to the SA node, with efferent branches forming the primary pathway for cardioinhibitory control, although some contribution from the left vagus exists. Physiologically, this parasympathetic modulation promotes the "rest and digest" state by maintaining basal suppression and overriding sympathetic influences during low-demand conditions, ensuring cardiovascular .

Clinical significance

SA node disorders

The sinoatrial (SA) disorders encompass a range of pathological conditions that impair the 's pacemaker activity, leading to abnormal heart rhythms. (SND), also known as sick sinus syndrome (SSS) when symptomatic, is the primary category, characterized by inadequate sinus impulse generation or conduction, resulting in bradyarrhythmias, tachyarrhythmias, or alternating patterns (tachy-brady syndrome). These disorders arise from intrinsic damage to the SA or surrounding atrial , often manifesting as , sinus pauses/arrest, or sinoatrial exit block. Causes of SND and SSS include age-related degeneration with sclerosing fibrosis replacing functional nodal cells, ischemia from sinoatrial nodal artery compromise (typically supplied by the right coronary artery in 60% of cases), post-surgical trauma such as from valve replacements or atrial ablation, and infiltrative diseases like amyloidosis, sarcoidosis, or hemochromatosis. Fibrosis is the most common intrinsic factor, progressively disrupting automaticity and conduction, while ischemia remains relatively rare due to the node's dual vascular supply. Among tachyarrhythmias linked to SA node pathology, inappropriate sinus tachycardia (IST) involves abnormal enhanced automaticity, leading to persistent resting heart rates exceeding 100 beats per minute without physiologic triggers; its etiology may include autonomic dysregulation or idiopathic nodal hypersensitivity, though exact mechanisms are not fully elucidated. Risk factors for these disorders prominently feature aging, with progressive correlating to slowed intrinsic heart rate and increased incidence; exacerbates ischemia-related damage, while rare congenital anomalies, such as mutations in or HCN4 genes, predispose to early-onset SND. Symptoms are nonspecific but include , syncope or presyncope, , , and exertional intolerance, often worsening with tachy-brady alternations in . In IST, patients commonly report , , and anxiety-like discomfort. Epidemiologically, SND affects older adults disproportionately, with an incidence of approximately 0.8 per 1,000 person-years overall, rising to over 4 per 1,000 in those aged 85 and above; prevalence reaches about 1 in 600 among cardiac patients over 65 years, with equal distribution across sexes.

Diagnostic and therapeutic implications

Diagnosis of sinoatrial node dysfunction relies on correlating clinical symptoms with electrocardiographic (ECG) findings, where standard ECG can identify characterized by regular P waves preceding each [QRS complex](/page/QRS complex) with a rate of 60-100 beats per minute. Holter monitoring is particularly useful for detecting intermittent sinus pauses or , capturing episodes over 24-48 hours that may not appear on a single ECG. Electrophysiological studies () provide more invasive assessment, measuring the corrected sinus node recovery time (CSNRT), with values exceeding 550 ms indicating abnormal sinoatrial node function. Imaging modalities such as assess overall cardiac structure and rule out associated pathologies like atrial enlargement, but they offer limited direct visualization of the sinoatrial node due to its small size. Cardiac (MRI) can detect atrial via late enhancement, which correlates with sinoatrial node dysfunction, though it is not routinely used for primary diagnosis. Therapeutic management for due to sinoatrial node dysfunction primarily involves permanent implantation, which is the mainstay treatment to maintain adequate s and alleviate symptoms; for selected cases such as hypervagotonic or functional SND, cardioneuroablation has emerged as an alternative to pacing. For tachycardic aspects, such as in , beta-blockers like metoprolol or are first-line to reduce , while targeting focal sites within or near the sinoatrial node is considered for refractory cases, achieving symptom relief in a majority of patients. In atrial surgeries, such as those for congenital heart defects or ablation, surgical techniques emphasize preservation of the sinoatrial node by careful incision placement and avoidance of its arterial supply to prevent iatrogenic injury leading to postoperative dysfunction. Prognosis following pacemaker implantation for sick sinus syndrome is generally favorable with improved , though approximately 80% of patients develop long-term dependency on the device, necessitating lifelong monitoring and potential battery replacements.

History and development

Historical discovery

The sinoatrial node was first identified in 1907 by anatomists and Martin Flack, who described it as a distinct structure at the junction of the and the right atrium in the hearts of various vertebrates, including and humans, proposing it as the origin of the heart's activity. Their histological observations revealed a collection of specialized muscle fibers forming an elongated mass, which they termed the "sino-auricular node," based on its position and presumed evolutionary connection to the in lower vertebrates. In 1910, physiologist Thomas Lewis provided experimental confirmation of the node's functional role as the heart's primary pacemaker through studies using the newly developed electrocardiogram (ECG) on and human subjects, demonstrating that the initial electrical excitation originated from this region. Lewis further refined the nomenclature to "sinu-atrial node" and mapped the spread of excitation from the node to the atria, establishing its dominance in initiating normal . Advancements in the mid-20th century, particularly through electron microscopy in the and , elucidated the cellular composition of the node, identifying "P cells" (pacemaker cells) as specialized myocytes with sparse myofibrils, abundant , and few gap junctions compared to surrounding atrial cardiomyocytes. These studies, conducted on and other mammalian models, highlighted the ultrastructural features enabling spontaneous , such as underdeveloped and prominent mitochondria. During the and , electrophysiological investigations uncovered key ionic mechanisms underlying the node's , with , Hugh Brown, and colleagues identifying the "funny current" (I_f) as a hyperpolarization-activated inward current carried by HCN channels, essential for the diastolic phase of the pacemaker . This discovery, first detailed in sinoatrial node preparations, explained how the node generates rhythmic impulses and responds to autonomic modulation. In the 2000s, high-resolution imaging and computational techniques enabled three-dimensional () mapping of the node's intramural , revealing it as a complex, elongated fibrotic structure extending subsurface within the right atrial wall, with heterogeneous fiber orientations and conduction pathways. These reconstructions, derived from serial histological sections and in and hearts, demonstrated the node's non-uniform and its with atrial myocardium, providing insights into arrhythmogenic vulnerabilities.

Embryological origins

The sinoatrial node (SAN) originates during the fifth week of human gestation from progenitors in the right posterior region of the and contributions from the second heart field, where myocardial cells begin to differentiate into tissue around embryonic day 35. These progenitors, marked by expression of Tbx18 and lacking Nkx2-5, form the initial SAN , while second heart field-derived cells, including those expressing Isl1, migrate to the venous pole to contribute to formation. Key transcription factors such as Tbx3, Shox2, and Hcn4 play critical roles in specifying the lineage; Tbx3 represses atrial working myocardial genes to maintain the nodal , Shox2 inhibits Nkx2-5 expression to promote pro- identity, and Hcn4 marks early in these cells. Isl1-positive cells from the second heart field integrate into the developing , supporting its positional establishment. During morphogenesis, the is incorporated into the wall of the right atrium through remodeling of the venous pole, where the integrates with the primitive atrium as the right superior cardinal vein regresses and the right sinus horn enlarges. This process, occurring between weeks 5 and 6, involves of specified primordial cells and formation of distinct head and tail domains, with the head arising from Tbx18-positive sinus venosus myocardium and the tail from Nkx2-5-positive cells. By the eighth week, the SAN matures functionally, developing spontaneous with characteristic action potentials that initiate coordinated heartbeats. Congenital anomalies, such as heterotaxy syndrome, disrupt normal left-right patterning and can alter SAN position; for instance, Pitx2 deficiency leads to bilateral or misplaced , often resulting in dual nodes or abnormal atrial isomerism that predisposes to arrhythmias. Evolutionarily, the SAN is conserved as a homologous pacemaker structure across vertebrates, with similar Tbx18-dependent mechanisms in the of and amphibians generating rhythmic activity akin to mammalian nodal function.

References

  1. [1]
    Physiology, Sinoatrial Node - StatPearls - NCBI Bookshelf
    The main function of the SA node is to act as the heart's normal pacemaker. It initiates an action potential that results in an electrical impulse traveling ...
  2. [2]
    Three-Dimensional Functional Anatomy of Human Sinoatrial node ...
    The sinoatrial node (SAN) is the primary pacemaker of the human heart. It is a single, elongated three-dimensional (3D) intramural fibrotic structure.
  3. [3]
    Myoarchitecture of the Sinoatrial Node and its Relevance for ...
    Dec 8, 2023 · The SAN is a crescent-shaped structure located subepicardially within the sulcus terminalis of the right atrium (RA), lying inferior to the crest of the right ...
  4. [4]
    Sinoatrial Node Structure, Mechanics, Electrophysiology and the ...
    Pacemaker cells in the SAN are interspersed with fibroblasts and embedded within a matrix of fibrous connective tissue, predominately consisting of collagen and ...
  5. [5]
    Telocytes in the human sinoatrial node - Wiley Online Library
    Nov 17, 2017 · They contain a few myofibrils, sparse mitochondria, a poorly developed sarcoplasmic reticulum and lysosomes. P cells typically occur in small ...
  6. [6]
    Comparative Ultrastructure of the Sinus Node in Man and Dog
    Each P cell is surrounded by a plasma membrane and groups of them are bound by a basement membrane. The only specialized junction between P cells is the ...
  7. [7]
    Ultrastructure of electrophysiologically identified human sinoatrial ...
    In summary, ultrastructural study of electrophysiologically documented human SA nodes confirmed the cell types identified in post-mortem studies.
  8. [8]
    Anatomical Variations in the Sinoatrial Nodal Artery: A Meta ...
    The most common origin of the SANa was from the right coronary artery (RCA), found in 68.0% (95%CI:55.6–68.9) of cases, followed by origin from the left ...
  9. [9]
    Anatomy, Thorax, Sinoatrial Nodal Artery - StatPearls - NCBI Bookshelf
    Dec 9, 2023 · The sinoatrial nodal artery is a branch of the main coronary arteries, or its derivatives, which supplies blood to the heart's pacemaker, the sinoatrial node.Missing: drainage | Show results with:drainage
  10. [10]
    Coronary Arteries and Veins - The Heart - TeachMeAnatomy
    The cardiac veins drain into the coronary sinus, which in turn, empties into the right atrium. There are also smaller cardiac veins which pass directly into the ...
  11. [11]
    Anatomy, Thorax, Coronary Sinus - StatPearls - NCBI Bookshelf
    Venous blood from the left arm, head, and neck drains directly into the coronary sinus before entering the right atrium. Although PLSVC is clinically silent ...Missing: sinoatrial node
  12. [12]
    Microvascular Rarefaction in the Sinoatrial Node: A Potential ... - JACC
    Jul 23, 2025 · To meet these metabolic demands, SA node myocytes depend on a dense vascular network that delivers oxygen and nutrients. The SA node artery, ...
  13. [13]
    The Organization of the Sinoatrial Node Microvasculature Varies ...
    During diastole, when the compressive forces of the myocardium are at their lowest, blood moves through SAN artery and capillary network to deliver oxygen to ...
  14. [14]
    Review: HCN Channels in the Heart - PMC - PubMed Central
    This review is focused on the pacemaking process taking place in the heart and summarizes the current knowledge on HCN channels.
  15. [15]
    The Functional Role of Hyperpolarization Activated Current (I f ) on ...
    The cardiac hyperpolarization-activated “funny” current (If), which contributes to sinoatrial node (SAN) pacemaking, has a more negative half-maximal activation ...
  16. [16]
    The Cardiac Pacemaker Story—Fundamental Role of the Na+/Ca2+ ...
    This review focuses on the role of the Na + /Ca 2+ exchanger from the early results and concepts to recent advances and attempts to give a balanced summary.
  17. [17]
    Neurohumoral Control of Sinoatrial Node Activity and Heart Rate
    In this review we discuss the coupled-clock pacemaker system and how its manipulation by neurohumoral signaling alters heart rate.
  18. [18]
    Overdrive Suppression - CV Physiology
    The higher frequency of SA nodal firing suppresses other pacemaker sites by a mechanism called overdrive suppression.
  19. [19]
    Conduction system of the heart: Parts and Functions | Kenhub
    These transition cells form bridges between P cells and surrounding atrial cells. The SA node receives its blood supply from the sinuatrial nodal branch of the ...Interatrial Conduction... · Physiology · Clinical Notes
  20. [20]
    Sinus Node - an overview | ScienceDirect Topics
    While impulse propagation occurs rapidly through the atria, conduction slows in the transitional cell zone that surrounds the compact AV node. Differential ...
  21. [21]
    Computational analysis of the human sinus node action potential - NIH
    We constructed a comprehensive mathematical model of the spontaneous electrical activity of a human sinoatrial node (SAN) pacemaker cell, starting from the ...<|separator|>
  22. [22]
    The Role of the Funny Current in Pacemaker Activity
    Feb 19, 2010 · The “funny” (If) current, originally described in sinoatrial node myocytes as an inward current activated on hyperpolarization to the diastolic ...
  23. [23]
    The Calcium and Voltage Clocks in Sinoatrial Node Automaticity - NIH
    We conclude that the Ca 2+ and voltage clocks work synergistically to generate SAN automaticity. Keywords: Calcium, Sinoatrial node, Sarcoplasmic reticulum, ...
  24. [24]
    Pacemaker current (I(f)) in the human sinoatrial node - PubMed
    Pacemaker cells generated spontaneous APs (cycle length 828 +/- 15 ms) following slow diastolic depolarization, maximal diastolic potential - 61.7 +/- 4.3 mV, ...
  25. [25]
    Cellular and Molecular Mechanisms of Functional Hierarchy of ...
    Apr 13, 2021 · The sinoatrial node (SAN), the primary pacemaker of the heart, consists of a heterogeneous population of specialized cardiac myocytes that ...
  26. [26]
    The Mechanism of Cardiac Sympathetic Activity Assessment Methods
    Jun 23, 2022 · Cardiac sympathetic nerves play a vital role in regulating sinoatrial node, atrioventricular node, and activity of the segmental myocardium, ...
  27. [27]
    Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart ...
    The sinoatrial node is primarily innervated by cardiac postganglionic sympathetic nerve terminals from the right stellate ganglion [78]. The conduction system, ...
  28. [28]
    Neurohumoral Control of Sinoatrial Node Activity and Heart Rate - NIH
    In this review we discuss the coupled-clock pacemaker system and how its manipulation by neurohumoral signaling alters heart rate.
  29. [29]
    Cardiac plexus | Radiology Reference Article | Radiopaedia.org
    Jul 20, 2025 · Postganglionic fibers from both components pass into the heart and are most densely distributed to the sinoatrial node and atrioventricular node ...
  30. [30]
    Physiology, Muscarinic Receptor - StatPearls - NCBI Bookshelf - NIH
    [1] The molecule acetylcholine activates muscarinic receptors, allowing for a parasympathetic reaction in any organs and tissues where the receptor is expressed ...
  31. [31]
    Regulation of Pacemaker Activity - CV Physiology
    The SA node displays intrinsic automaticity (spontaneous pacemaker activity) at a rate of 100-110 action potentials (“beats”) per minute.Missing: exchanger | Show results with:exchanger
  32. [32]
    Autonomic Ganglia - CV Pharmacology
    In the heart because vagal influences override sympathetic effects, there is a resting vagal tone that maintains a low-resting heart rate. In contrast, most ...
  33. [33]
    Sick Sinus Syndrome - StatPearls - NCBI Bookshelf - NIH
    Sick sinus syndrome, also known as sinus node dysfunction, is a disorder of the sinoatrial node caused by impaired pacemaker function and impulse transmission.Continuing Education Activity · Etiology · Evaluation · Treatment / Management
  34. [34]
    Sinus Node Dysfunction - StatPearls - NCBI Bookshelf
    The symptoms of sinus node dysfunction are non-specific and include lightheadedness, fatigue, presyncope, and syncope. For patients who have tachy-brady ...
  35. [35]
    Sick sinus syndrome - Symptoms & causes - Mayo Clinic
    Sick sinus syndrome causes slow heartbeats, pauses (long periods between heartbeats) or irregular heartbeats (arrhythmias). Sick sinus syndrome is relatively ...
  36. [36]
    Sinus Tachycardia - StatPearls - NCBI Bookshelf
    Sinus tachycardia is a regular cardiac rhythm in which the heart beats faster than normal and results in an increase in cardiac output.
  37. [37]
    Incidence of and Risk Factors for Sick Sinus Syndrome in the ...
    Typical symptoms of SSS include syncope, dizziness, palpitations, exertional dyspnea, easy fatigability from chronotropic incompetence, heart failure, and ...
  38. [38]
    Sick sinus syndrome: MedlinePlus Medical Encyclopedia
    Feb 27, 2024 · An intracardiac electrophysiology study (EPS) is a very specific test for this disorder. ... Bradycardia-tachycardia syndrome; Sinus node ...Missing: methods | Show results with:methods
  39. [39]
    Normal values for corrected sinus node recovery time in adolescents
    Normal values for corrected sinus node recovery time (CSNRT) are generally accepted as 275 and 500-550 msec in young children and adults, respectively.
  40. [40]
    Noninvasive Imaging of Sinus Node Disease: Can It Predict the ...
    Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. Journal of ...
  41. [41]
    Targeted Treatment of Inappropriate Sinoatrial Node Tachycardia ...
    Nov 15, 2022 · Long-acting β blockers in IST can act on both primarily increased automaticity and dysregulated autonomic system. Ivabradine targets sources ...
  42. [42]
    Catheter ablation for inappropriate sinus tachycardia - NIH
    The aim of this study was to assess clinical outcomes of sinus node (SN) ablation for the treatment of drug-refractory IST.
  43. [43]
    Protection of the sinus node in Mustard's operation - PubMed
    Protection of the sinus node in Mustard's operation. Circulation. 1976 May;53(5):788-91. doi ... Sinoatrial Node*; Transposition of Great Vessels / surgery*
  44. [44]
    Sick Sinus Syndrome | Heart and Vascular - UC Davis Health
    May 25, 2023 · Long-term atrial fibrillation can sometimes change how your sinus node works, resulting in dysfunction. Connective Tissue Diseases. Connective ...Missing: methods | Show results with:methods
  45. [45]
    New Insights Into Pacemaker Activity | Circulation
    Apr 10, 2007 · The syndrome occurs in 1 of every 600 cardiac patients older than 65 years and accounts for approximately half of implantations of pacemakers in ...
  46. [46]
    A 21st century view of the anatomy of the cardiac conduction system
    Electron microscopy, developed from the 1930s, has opened up the subcellular nanoworld, revealing the organelles within cells and the compartmentalization of ...
  47. [47]
    Computer Three-Dimensional Reconstruction of the Sinoatrial Node
    Feb 7, 2005 · Conclusions— For the first time, a 3D anatomically detailed mathematical model of the SAN has been constructed, and this shows the presence of a ...Missing: original studies
  48. [48]
    Human Sinoatrial Node Structure - PubMed Central - NIH
    The human SAN is 1-2mm thick and extends through hundreds of serial-sectioned histology slides. As such, analysis of a limited number of 2D slides is ...
  49. [49]
    The development of cardiac rhythm - PMC - NIH
    THE ORIGIN OF NODAL CELLS. The nodal cells of the AV and SA node are similar to embryonic cardiomyocytes. They are small with a poorly developed sarcoplasmic ...
  50. [50]
    Genetic Regulation of Sinoatrial Node Development and Pacemaker ...
    Nov 30, 2015 · The definitive sinoatrial node (SAN), the primary pacemaker of the mammalian heart, develops from part of pro-pacemaking embryonic venous pole ...
  51. [51]
    Development of the Pacemaker Tissues of the Heart
    Feb 5, 2010 · At the entrance of the right atrium, sinus node (sinoatrial node [SAN]) myocytes generate the impulse to activate the atrial myocardium. After ...The Sinus Node And Its... · Tbx3 Transcriptional... · The Avn And Its Markers
  52. [52]
    On the Evolution of the Cardiac Pacemaker - PMC - PubMed Central
    Apr 27, 2017 · Understanding the evolutionary origin and development of cardiac pacemaker cells will help us outline the important pathways and factors involved.